10-Q: Beyond Meat Faces Revenue Drop, Posts $57M Impairment Charge

Beyond Meat reported a 8.1% decrease in net revenues for the third quarter of 2026, alongside a significant $57.1 million impairment charge, highlighting ongoing challenges in the plant-based meat market.

Summary

• Beyond Meat's net revenues for the third quarter of 2026 decreased by 8.1% to $64.5 million compared to the same period in 2025, and for the nine-month period, revenues fell by 10.4% to $191.6 million.
• The company recorded a significant loss from impairment of long-lived assets totaling $57.1 million for the nine months ended September 26, 2026.
• Net loss for the nine months ended September 26, 2026 was $94.9 million, an improvement from $189.9 million in the prior year period.
• Gross profit increased substantially to $12.4 million in Q3 2026 from $5.2 million in Q3 2025, with gross margin improving to 19.3% from 7.4%.
• Research and development expenses increased significantly by 211.0% in Q3 2026, largely due to accelerated rent expenses from lease modifications.
• Total SG&A expenses decreased by 30.0% in Q3 2026, primarily due to a reduction in litigation accruals, but were impacted by accelerated rent expenses.
• The company continues to face challenges including declining demand in the plant-based meat category, macroeconomic headwinds, and competitive pressures.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative score due to continued revenue decline, significant impairment charges, and ongoing net losses, despite some improvements in gross margin.

Positives

• Gross profit for the three months ended September 26, 2026 increased by 137.6% to $12.4 million, with gross margin improving to 19.3% from 7.4% in the prior year.
• Net loss for the nine months ended September 26, 2026 decreased to $94.9 million from $189.9 million in the prior year.
• Total SG&A expenses decreased by 30.0% in Q3 2026, largely due to a $21.8 million reduction in litigation accruals related to the Sonate Trademark Infringement Litigation.
• International retail net revenues saw an increase of 13.3% in Q3 2026, driven by higher volume and price realization.
• The company regained compliance with Nasdaq's minimum bid price requirement following a 1-for-30 reverse stock split.

Negatives

• Total net revenues decreased by 8.1% in Q3 2026 to $64.5 million and by 10.4% for the nine-month period to $191.6 million.
• A significant loss from impairment of long-lived assets totaling $57.1 million was recognized for the nine months ended September 26, 2026.
• Research and development expenses increased by 211.0% in Q3 2026, largely due to accelerated rent expenses from lease modifications.
• The company continues to experience declining demand in the plant-based meat category, particularly in the U.S. refrigerated segment.
• The company has a history of net losses and negative cash flows from operating activities, with ongoing liquidity concerns.
• The company no longer satisfies the eligibility requirements for use of a registration statement on Form S-3, limiting its ability to access its ATM Program.

Risks

• The strategic repositioning to 'Beyond The Plant Protein Company' may not be successful, potentially leading to brand dilution, consumer confusion, and diversion of resources.
• The company faces significant near-term obligations, including the maturity of $14.5 million in 2027 Notes on March 15, 2027, and covenants under its Loan and Security Agreement and 2030 Notes Indenture.
• Failure to maintain Nasdaq listing requirements could lead to delisting, adversely affecting stock value, liquidity, and the ability to raise capital, potentially triggering repurchase obligations for outstanding notes.
• The company's ability to raise additional capital is limited due to no longer meeting Form S-3 eligibility and ATM Program access, increasing reliance on existing cash and potential future financing.
• The company did not complete the surrender and restoration of leased space at its Campus Headquarters by the specified date, leading to potential damages, claims, and default risks under the lease and loan agreements.
• Ongoing declines in demand for plant-based meat products and macroeconomic headwinds pose a continuous risk to revenue generation and profitability.
• The company is subject to significant litigation, including a $15.4 million judgment in the Sonate Trademark Infringement Litigation, which remains subject to further proceedings.
• Regulatory uncertainty regarding the labeling and marketing of plant-based products, particularly in international markets, could impact product sales and marketing strategies.

Future Outlook

The company anticipates continued losses for the foreseeable future and expects to seek additional capital through equity and/or debt offerings. Future performance depends on achieving revenue and cash flow targets, managing costs, and successfully executing strategic initiatives, including expansion into new product categories. Liquidity remains a concern, with significant near-term obligations and limited access to capital markets.

Management Comments

• We seek to deliver the power of plants to consumers through our plant-based meat products, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating our plant-based meat products, and adjacent products that deliver taste and macronutrients from plants and plant-based ingredients.
• As demand for plant-based meat products in the U.S. has continued to decline persistently over the past few years, we have continued to adjust to the changing market landscape and evolving patterns in consumer demand to position our Company for long-term growth.
• A key component of achieving our long-term business strategy is to achieve cost leadership and continue driving the cost of our core products down over time.
• We believe that our existing cash balances, including our anticipated cash flows from operating activities, will be sufficient to fund our operations and meet our foreseeable cash requirements, including repayment of the 2027 Notes at their maturity and maintaining compliance with the minimum liquidity covenants under the Loan and Security Agreement and the 2030 Notes Indenture, for at least the next twelve months.

Industry Context

StockSavvy.ai notes that Beyond Meat's performance reflects broader challenges within the plant-based meat sector, characterized by declining demand and increased competition. The company's strategic pivot to 'Beyond The Plant Protein Company' and expansion into adjacent categories like beverages and protein powders are attempts to diversify and find new growth avenues amidst these industry headwinds.

Comparison to Industry Standards

• Beyond Meat's revenue decline of 8.1% in Q3 2026 contrasts with the overall food industry's performance, which has seen more stable or growing revenues in many segments, though plant-based alternatives have faced specific headwinds.
• The significant impairment charge of $57.1 million highlights potential overvaluation or underperformance of assets relative to market conditions, a situation not uncommon in high-growth sectors that experience rapid expansion followed by market recalibration.
• The company's gross margin improvement to 19.3% is a positive step but remains below the typical margins seen in more established food categories, indicating ongoing pressure on production costs and pricing power.
• The net loss of $94.9 million for nine months, while reduced from the prior year, still indicates a substantial gap between expenses and revenues, a common challenge for companies in evolving markets attempting to scale.

Legal Proceedings

• Aliments BVeggie, Inc. legal proceedings seeking damages of approximately 129,841,920 CAD.
• Consumer Class Actions Regarding Protein Claims: Settlement agreement reached, with the company contributing $7.5 million to a settlement fund.
• Arbitration with Former Co-Manufacturer: Settlement reached for $11.0 million, with $7.1 million received on July 10, 2026.
• Trademark Infringement Litigation (Sonate Corporation): Jury awarded $23.5 million in actual damages and $15.4 million in disgorgement of profits; court reduced actual damages to $37,500 and entered judgment for $15.4 million. Company is pursuing post-trial and appellate remedies.
• Aljendan v. Beyond Meat, Inc. et al.: Class action complaint alleging false and misleading statements regarding asset values and impairment charges; motion to dismiss pending.
• Consolidated Derivative Action (Azima, Davis, Perrow): Shareholder derivative actions alleging breach of fiduciary duty and misleading statements; case stayed pending resolution of Aljendan Action.

Related Party Transactions

• Sales to Zandbergen Entities generated $9.4 million in net revenues in Q3 2026 and $27.8 million for the nine-month period.
• Cost of goods sold related to Zandbergen Entities was $5.6 million in Q3 2026 and $17.1 million for the nine-month period, primarily for contract manufacturing and warehousing.
• Beyond Meat BV entered into an employment agreement with Adriaan Figee, General Manager, EMEA, effective July 1, 2026, with a base salary of €325,000.
• The company paid Mr. Figee $150,000 in consulting fees in the nine months ended September 26, 2026, under a consulting agreement that terminated June 30, 2026.
• The company has various contracts with Zandbergen entities for distribution, manufacturing, and cold storage, where Mr. Figee's immediate family members have financial interests or roles.

Stakeholder Impact

• Shareholders may experience further dilution due to potential future equity issuances and the conversion of convertible notes.
• Creditors face ongoing liquidity concerns and potential default risks if the company cannot meet its debt obligations.
• Employees may be impacted by ongoing cost-reduction initiatives, including potential workforce reductions.
• Suppliers and co-manufacturers may face payment uncertainties given the company's liquidity challenges.
• Customers may experience changes in product availability or pricing due to strategic shifts and market pressures.

Next Steps

• Continue to implement cost-reduction initiatives and the Global Operations Review.
• Focus on driving margin recovery and operating expense reduction.
• Manage inventory levels to generate cash flow.
• Invest in capital projects to reduce production costs.
• Pursue expansion into new, adjacent product categories (beverages, protein powders, jerky bars).
• Seek additional capital through equity and/or debt offerings.
• Address ongoing litigation and potential liabilities.
• Continue efforts to regain and maintain compliance with Nasdaq listing requirements.

Key Dates

Recommendation

While the company has shown some operational improvements like gross margin expansion and reduced SG&A, the persistent revenue decline, significant impairment charges, ongoing net losses, and substantial debt obligations present considerable risks. The strategic pivot and efforts to diversify are positive but unproven. The company's ability to navigate its liquidity challenges and execute its turnaround plan remains uncertain, warranting a cautious 'hold' stance.

Keywords

Beyond Meat, 10-Q, Quarterly Report, Financial Statements, Impairment Charge, Revenue Decline, Plant-Based Meat, Convertible Notes